Cargando…

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review

Ketamine, an anesthetic available since 1970, and esketamine, its newer S‐enantiomer, provide a novel approach for the treatment of depression and other psychiatric disorders. At subanesthetic doses, the two drugs, along with their older congener, phencyclidine (PCP), induce a transient, altered men...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Thomas J., Alami, Abdallah, Alexander, G. Caleb, Mattison, Donald R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review of Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540857/ https://www.ncbi.nlm.nih.gov/pubmed/35665948 http://dx.doi.org/10.1002/phar.2707

Ejemplares similares

NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013)

Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells
por: Peduto Eberl, L, et al.
Publicado: (2003)

Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK
por: Bjerre, Lise M, et al.
Publicado: (2018)

Allosteric antagonist action at triheteromeric NMDA receptors
por: Gibb, Alasdair J.
Publicado: (2022)

Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism
por: Peterson, Sean M., et al.
Publicado: (2023)

Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study
por: Moore, Thomas J, et al.
Publicado: (2020)

An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium
por: Keedwell, R G, et al.
Publicado: (2004)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
por: Bartsch, Caitlyn J., et al.
Publicado: (2022)

Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome
por: Wei, Li, et al.
Publicado: (2008)

Brain NMDA Receptors in Schizophrenia and Depression
por: Adell, Albert
Publicado: (2020)

Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
por: Benvenutti, Radharani, et al.
Publicado: (2022)

Efficacy, Safety, and Tolerability of ONO‐4474, an Orally Available Pan‐Tropomyosin Receptor Kinase Inhibitor, in Japanese Patients With Moderate to Severe Osteoarthritis of the Knee: A Randomized, Placebo‐Controlled, Double‐Blind, Parallel‐Group Comparative Study
por: Ishiguro, Naoki, et al.
Publicado: (2019)

Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies
por: Carvajal, Francisco J., et al.
Publicado: (2016)

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
por: Kaufmann, Carole P, et al.
Publicado: (2015)

Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts
por: Purohit, A, et al.
Publicado: (2003)

Effects of the Novel NMDA Receptor Antagonist Gacyclidine on Recovery From Medial Frontal Cortex Contusion Injury in Rats
por: Smith, Jeffrey S., et al.
Publicado: (2000)

The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice
por: Kos, Tomasz, et al.
Publicado: (2010)

NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception
por: Meuwese, Julia D. I., et al.
Publicado: (2013)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury
por: Li, Yang, et al.
Publicado: (2015)

Safety Exposure‐Response Analysis for Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV‐Infected Subjects
por: Osawa, Mayu, et al.
Publicado: (2018)

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers
por: Bajo, A M, et al.
Publicado: (2004)

Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma
por: Chen, L, et al.
Publicado: (2014)

The Role of NMDA Receptor Antagonists in Nicotine Tolerance, Sensitization, and Physical Dependence: A Preclinical Review
por: Jain, Raka, et al.
Publicado: (2008)

Double Dissociation of Spike Timing–Dependent Potentiation and Depression by Subunit-Preferring NMDA Receptor Antagonists in Mouse Barrel Cortex
por: Banerjee, Abhishek, et al.
Publicado: (2009)

Safety of lamotrigine in paediatrics: a systematic review
por: Egunsola, Oluwaseun, et al.
Publicado: (2015)

NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells
por: Cyranka, Malgorzata, et al.
Publicado: (2022)

Reviewing Evidence for the Usefulness of Family Interventions for Depression During and After the COVID-19 Pandemic
por: Keitner, G.
Publicado: (2022)

Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086
por: Cellai, C, et al.
Publicado: (2006)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi
por: Santos Souza, Higo Fernando, et al.
Publicado: (2019)

Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities
por: Torres, Eva, et al.
Publicado: (2012)

Inhibition of Acetylcholinesterase Modulates NMDA Receptor Antagonist Mediated Alterations in the Developing Brain
por: Bendix, Ivo, et al.
Publicado: (2014)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: Zeiler, F. A.
Publicado: (2015)

Use and safety of azithromycin in neonates: a systematic review
por: Smith, Coral, et al.
Publicado: (2015)

Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data
por: Warkentin, Lisette, et al.
Publicado: (2023)

Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
por: Pozzi, Laura, et al.
Publicado: (2014)

Adverse effects information in clinical guidelines on pharmacological treatment of depression in children and adolescents: a systematic review
por: Westergren, Tone, et al.
Publicado: (2020)

NMDA and Dopamine Converge on the NMDA-Receptor to Induce ERK Activation and Synaptic Depression in Mature Hippocampus
por: Kaphzan, Hanoch, et al.
Publicado: (2006)

Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects
por: Eckburg, Paul B., et al.
Publicado: (2019)

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
por: Zakaria, Z, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vslgdfaavr38trirndrcnb4sln